For tiende år på rad kunne Jónas Einarsson, administrerende direktør i Radforsk Investeringsstiftelse og initiativtaker til Oslo Cancer Cluster Innovasjonspark, ønske velkommen til samarbeidsdagene på Ullern videregående skole.
Three finalists are shortlisted for the Norwegian Cancer Society Innovation Prize.
Meet the members who joined our cluster so far this year.
Under the banner “Catalyzing Collaborations for Global Impact,” the CONNECT Nordics symposium challenged European actors to move beyond borders and build the partnerships needed to drive the next generation of cancer innovation.
The Cell Therapy Innovation Symposium gathered scientists, process developers, and industry leaders from across Europe to explore the latest advances and challenges in immune cell therapy manufacturing.
Oslo Cancer Cluster brought together leading experts from across the Nordics, the UK, and the US for a full-day symposium focused on lung cancer screening.
Get monthly news updates and invitations to events from our oncology cluster.
Scientists are developing new CAR-T cell therapy in their laboratories located at Oslo Cancer Cluster Incubator.
The PREDI-LYNCH project kicks off in Heidelberg.
The partnership between Oslo Cancer Cluster and Ullern Upper Secondary School marks its 15th anniversary in 2025. The milestone was celebrated at Oslo Cancer Cluster Innovation Park on 15 September with a lively programme.
AdjuTec Pharma has been awarded a €2.2 million Eurostars grant together with international partners. The funding will support the development of new drug combinations for patients suffering from severe lung infections caused by multidrug-resistant bacteria.
The Norwegian Cancer Society is pleased to announce the opening of nominations for its 2025 Innovation Prize.
Hvordan nå de helsepolitiske ambisjonene samtidig som vi prioriterer riktig? Dette var hovedspørsmålet på frokostseminaret Fremtidens kreftbehandling under Arendalsuka 2025.
